Issues and Practicalities of Treating Genital Warts in the Community: Proceedings of a round Table Meeting Held on 13 February 2001

Teenage Pregnancy. London: Stationery Office, June 1999

PHLS (England, Wales & Northern Ireland), DHSS & PS (Northern Ireland) and the Scottish ISD(D)5 Collaborative Group (ISD, SCIEH and MSSVD). Trends in Sexually Transmitted Infections in the United Kingdom 1990-1999. New Episodes Seen at Genitourinary Medicine Clinic.

[www.doh.gov.uk/nshs/index.htm]

Department of Health, Statistics Division 1E, Prescription Cost Analysis System

Maw R.D. , Reitano M. , Roy M. . An international survey of patients with genital warts; perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998; 9: 571–8

Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of anogenital warts. Sex Trans Inf 1999; 75(suppl. 1): S71–5

Silins I. , Dillner J. . Interactions between different HPV types. Papillomavirus Rep 2000; 11: 49–52

Beutner K.R. , Ferenczy A. . Therapeutic approaches to genital warts. Am J Med 1997; 102(5A): 28–37

Edwards L. , Ferenczy A. , Eron L. . Self-administered topical 5% Imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25–30

Beutner K.B. , Tyring S.K. , Trofatter K Jr .,. Imiquimod, a patient-applied immune response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998; 42(4): 789–94

Langley P.C. , Tyring S.K. , Smith M.H. . The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts. Am J Managed Care 1999; 5: 69–77